§ 12-507

391 words·~2 min read·/md/health-occupations/12-507

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

§12–507.

(a)A pharmacist who provides prescription services to medical assistance recipients shall offer to discuss with each medical assistance recipient or caregiver who presents a prescription order for outpatient drugs any matter which, in the exercise of the pharmacist’s professional judgment, the pharmacist deems significant, which may include the following:

(1)The name and description of the medication;

(2)The route, dosage form, dosage, route of administration, and duration of drug therapy;

(3)Special directions and precautions for preparation, administration, and use by the patient;

(4)Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur;

(5)Techniques for self-monitoring drug therapy;

(6)Proper storage;

(7)Prescription refill information; and

(8)Action to be taken in the event of a missed dose.

(b)The offer to discuss may be made in the manner determined by the professional judgment of the pharmacist, which shall include either:

(1)A face-to-face communication with the pharmacist; or

(2)At least 2 of the following:

(i)A sign posted so it can be seen by patients;

(ii)A notation affixed to or written on the bag in which the prescription is to be dispensed;

(iii)A notation contained on the prescription container; or

(iv)Communication by telephone.

(c)Nothing in this section shall be construed as requiring a pharmacist to provide consultation if the medical assistance recipient or caregiver refuses the consultation.

(d)A pharmacist must make a reasonable effort to obtain, record, and maintain, at the individual pharmacy, at least the following information regarding a medical assistance recipient:

(1)Name, address, telephone number, date of birth or age, and gender;

(2)Individual history when significant, including disease state or states, known allergies and drug reactions, and a comprehensive list of medications and relevant devices; and

(3)Pharmacist comments relevant to the individual’s drug therapy which may be recorded either manually or electronically in the patient’s profile.

(e)This section shall apply only to medical assistance recipients presenting prescriptions for covered outpatient drugs.

(f)The requirements of this section do not apply to refill prescriptions.

(g)The Secretary, after consultation with the Maryland Pharmacists Association and the Maryland Association of Chain Drug Stores, shall adopt regulations in accordance with pharmacy practices in Maryland to implement the provisions of this section.